Dupilumab Subcutaneous and NovoLog PenFill
Determining the interaction of Dupilumab Subcutaneous and NovoLog PenFill and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dupilumab
Brand name: Dupixent
Synonyms: Dupilumab
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dupilumab Subcutaneous-Novoseven
- Dupilumab Subcutaneous-NovoSeven RT
- Dupilumab Subcutaneous-NovoSeven RT with MixPro injection
- Dupilumab Subcutaneous-Novothyrox
- Dupilumab Subcutaneous-Noxafil
- Dupilumab Subcutaneous-Noxafil (Posaconazole Delayed-Release Tablets)
- NovoLog PenFill-Dupixent
- NovoLog PenFill-Duplex T Topical
- NovoLog PenFill-Durachol
- NovoLog PenFill-Duraclon
- NovoLog PenFill-Duraclon injection
- NovoLog PenFill-Duraflu